(Q48444056)

11 February 2018

title

Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice (English)

1 reference

11 February 2018

1 reference

1 reference

3

1 reference

11 February 2018

Hideki Yokoi

8

1 reference

11 February 2018

author name string

H Makino

1

1 reference

11 February 2018

M Mukoyama

2

1 reference

11 February 2018

T Suganami

4

1 reference

11 February 2018

M Kasahara

5

1 reference

11 February 2018

K Yahata

6

1 reference

11 February 2018

T Nagae

7

1 reference

11 February 2018

K Sawai

9

1 reference

11 February 2018

Y Ogawa

10

1 reference

11 February 2018

S Suga

11

1 reference

11 February 2018

Y Yoshimasa

12

1 reference

11 February 2018

A Sugawara

13

1 reference

11 February 2018

I Tanaka

14

1 reference

11 February 2018

K Nakao

15

1 reference

11 February 2018

publication date

18 August 2006

1 reference

11 February 2018

published in

Diabetologia

1 reference

11 February 2018

volume

49

1 reference

11 February 2018

issue

10

1 reference

11 February 2018

page(s)

2514-2524

1 reference

11 February 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-006-0352-Y

Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycaemic control

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-006-0352-Y

Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy

21 January 2018

1 reference

12 December 2020

The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.

1 reference

12 December 2020

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

1 reference

12 December 2020

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

1 reference

12 December 2020

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

12 December 2020

Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy

1 reference

12 December 2020

Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway

1 reference

12 December 2020

Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist

1 reference

12 December 2020

The natriuretic peptide family.

1 reference

12 December 2020

Clinical practice. Nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure

1 reference

12 December 2020

Biochemistry and molecular cell biology of diabetic complications

1 reference

12 December 2020

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

12 December 2020

Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides

1 reference

12 December 2020

Overview: combating diabetic nephropathy

1 reference

12 December 2020

Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption

1 reference

12 December 2020

Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone.

1 reference

12 December 2020

Mitogen-activated protein kinases as glucose transducers for diabetic complications

1 reference

12 December 2020

Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide

1 reference

12 December 2020

Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes

1 reference

12 December 2020

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

1 reference

12 December 2020

The family of guanylyl cyclase receptors and their ligands

1 reference

12 December 2020

Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration

1 reference

12 December 2020

Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells.

1 reference

12 December 2020

High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy

1 reference

12 December 2020

Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells

1 reference

12 December 2020

Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats

1 reference

12 December 2020

Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide

1 reference

12 December 2020

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

1 reference

12 December 2020

Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress

1 reference

12 December 2020

Role of Insulin and Atrial Natriuretic Peptide in Sodium Retention in Insulin-Treated IDDM Patients During Isotonic Volume Expansion

1 reference

12 December 2020

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

1 reference

12 December 2020

Pathways to nephron loss starting from glomerular diseases-insights from animal models

1 reference

12 December 2020

Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury.

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria

1 reference

12 December 2020

Atrial natriuretic peptide in diabetic nephropathy

1 reference

12 December 2020

Podocyte loss and progressive glomerular injury in type II diabetes

1 reference

12 December 2020

Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group

1 reference

12 December 2020

Reversal of lesions of diabetic nephropathy after pancreas transplantation

1 reference

12 December 2020

Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation

1 reference

12 December 2020

Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions

1 reference

12 December 2020

Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome

1 reference

12 December 2020

10.1007/S00125-006-0352-Y

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018